Physician profile
Nathan D Murray
NPI 1215261367
$376.55
in general payments reported to CMS, 2019-2025
12 companies · $102 in 2025
The $102 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.64 · 2022: $145 · 2023: $13.28 · 2024: $100 · 2025: $102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $215.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $110.38 | 2022 | |
| Zimmer Biomet Holdings, INC. | $50.00 | 2025 | Gel-One Cross-Linked Hyaluronate |
| Otsuka America Pharmaceutical, INC. | $37.63 | 2024 | Rexulti |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.46 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.18 | 2024 | |
| Lundbeck LLC | $20.40 | 2024 | Rexulti |
| Glaxosmithkline, LLC. | $19.60 | 2025 | Trelegy Ellipta |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $17.93 | 2024 | Caplyta |
| Pfizer INC. | $16.70 | 2025 | |
| Novartis Pharmaceuticals Corporation | $16.64 | 2021 | |
| Novo Nordisk INC | $15.35 | 2025 | Ozempic, Rybelsus |
| Lilly USA, LLC | $13.28 | 2023 | Jardiance, Emgality |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Murray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.